Today's Benzinga Interviews is all about breakthrough therapies for Generalized Anxiety Disorder and ADHD. #ADHD #GAD #LSD #FDA #LSDTherapy #BiotechIndustry
Guests: Robert Barrow is CEO of Nasdaq-listed Mind Medicine (MindMed)
With a Bachelor in Science and a Masters in Pharmacology, Robert holds over a decade of serving as a pharmaceutical executive and clinical pharmacologist, as well as in regulatory consulting roles for psychedelics companies -startups to Fortune 500.
He joined MindMed as Chief Development Officer in 2021, was named interim CEO by mid-year, and elected CEO that December.
Hosted by: Lara Goldstein
